Skip to main content
Back
Watch Compare

KYNTRA BIO, INC.

Data quality: 100%
KYNB
Nasdaq Manufacturing Chemicals
$7.17
▼ $0.02 (-0.28%)
Mkt Cap: 29.10 M
Price
$7.19
Mkt Cap
29.10 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -59.33% annually over 5 years
Net margin of 2848.63% shows strong profitability
Negative free cash flow of -4.81 M
P/E of 0.16 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 18.93%
Capital efficient — spends only 0.59% of revenue on capex

Growth

Revenue Growth (5Y)
-59.33%
Below sector avg (1.82%)
Revenue (1Y)-78.26%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-58.86%
Net Margin2848.63%
Op. Margin-712.66%

Safety

Debt / Equity
N/A
Current Ratio3.71
Interest Coverage-5.24

Valuation

PE (TTM)
0.16
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E 0.2 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % 2848.6 -41.5
Rev Growth 5Y % -59.3 1.8
D/E — 0.3

Analyst Price Target

1 analyst
Buy
Current
$7.17
+499.7%
Target
$43.00
$43.00
$43.00
$43.00
Forecast
Forward P/E -0.70
Forward EPS -$10.25
Est. Revenue 5.15 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$10.25
-$11.54 – -$8.96
 5.15 M 2
FY2026 -$13.54
-$15.80 – -$11.28
 5.15 M 2

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$3.89 -$3.51 +9.7%
Q32025 -$4.01 $49.61 +1338.7%
Q22025 $1.00 -$1.88 -288.0%
Q12025 $0.50 $1.25 +150.0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -78.26% Revenue Growth (3Y) -79.12%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -59.33% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6.44 M Net Income (TTM) 183.45 M
ROE N/A ROA 116.45%
Gross Margin N/A Operating Margin -712.66%
Net Margin 2848.63% Free Cash Flow (TTM) -4.81 M
ROIC -58.86% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.71
Interest Coverage -5.24 Asset Turnover 0.04
Working Capital 97.45 M Tangible Book Value -17.03 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0.16 Forward P/E N/A
P/B Ratio N/A P/S Ratio 4.52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16.54%
Market Cap 29.10 M Enterprise Value -13.88 M
Per Share
EPS (Diluted TTM) 45.37 Revenue / Share 1.59
FCF / Share -1.19 OCF / Share -1.18
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.59% FCF Conversion -2.62%
SBC-Adj. FCF -17.89 M Growth Momentum -18.93

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6.44 M 29.62 M 147.75 M 140.73 M 235.31 M
Net Income 183.45 M -47.58 M -284.23 M -293.65 M -290.02 M
EPS (Diluted) 45.37 -0.48 -2.92 -3.14 —
Gross Profit — — — — —
Operating Income -45.90 M -150.42 M -281.82 M -301.03 M -288.53 M
EBITDA — — — — —
R&D Expenses 23.52 M 95.69 M 282.86 M 296.79 M 387.04 M
SG&A Expenses 27.71 M 49.33 M 115.25 M 124.69 M 123.93 M
D&A — — — — —
Interest Expense 8.76 M 8.25 M 15.53 M 1.44 M 1.08 M
Income Tax -90,000.0 -269,000.0 3,000.0 358,000.0 347,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 119.59 M 214.53 M 423.53 M 610.09 M 773.82 M
Total Liabilities 115.12 M 398.16 M 585.73 M 611.57 M 544.71 M
Shareholders' Equity -30.04 M -225.60 M -204.17 M -21.45 M 209.15 M
Total Debt 75.00 M — — — —
Cash & Equivalents 47.87 M 50.48 M 113.69 M 155.70 M 171.22 M
Current Assets 99.07 M 196.51 M 331.56 M 492.83 M 474.06 M
Current Liabilities 29.24 M 133.31 M 217.67 M 273.56 M 225.50 M